To answer this question, Sidekick Health entered a partnership with Bayer in 2019 and launched a digital medication management and lifestyle change platform for patients with PAD.
The most recent feasibility study by Sidekick was presented at the American Heart Association’s EPI Lifestyle conference in 2022 and published in the conference proceedings in Circulation. The results showed that its novel Digital Therapeutic Program is feasible for patients with PAD. In this article, we’ll guide you through the study and investigate how PAD affects patients.
Living with PAD
Peripheral artery disease is a progressive disorder characterized by the narrowing or blockage of arteries, excluding those that supply the heart or the brain. It’s estimated that more than 200 million people have PAD globally. Symptoms range from none to severe and can include recurrent fatigue, cramping, and pain known as intermittent claudication, which affects the lower limbs more than upper extremities.
Combined with the progression of the disease, the above symptoms can substantially impair individuals’ physical functionality and have a negative impact on the ability to perform daily activities, leading to disability and a subsequent loss of independence.
PAD reduces the quality of life significantly and can lead to serious complications, including amputation and death.
Supporting patients in managing the symptoms, adhering to treatment, and modifying risk factors is therefore essential for controlling the disease and preventing serious complications.
Peripheral Artery Disease: The Need for Data
However, data is limited regarding the feasibility and effectiveness of an accessible digital program supporting patients with PAD. In response, Sidekick has developed a novel Digital Therapeutic Program to help patients with PAD incorporate healthy lifestyle changes and adhere to treatment, ultimately leading to better disease management and improved quality of life.
The program is delivered through a smartphone app and includes medication reminders, patient education, food logging, mindfulness training, and exercise and movement tracking. The key features of the PAD program are remote patient monitoring, altruistic rewards to motivate users for completing missions, and access to lifestyle coaches.
The results from our feasibility study show that this digital therapeutic solution is feasible among patients with PAD, showing promise for real-world application. The section below features a summary of the study.
The study was a single-arm, interventional feasibility study that was conducted over four weeks. In this study:
- Fourteen elderly patients with PAD were enrolled from two vascular surgery clinics in Sweden.
- Participants used a therapeutic program delivered via a smartphone app.
- In-app data to assess the program’s feasibility was gathered throughout the study, while secondary clinical endpoints were assessed at baseline and follow up.